Apparent involvement of opioid peptides in stress-induced enhancement of tumor growth.
Exposure to stress has been associated with alterations in both immune function and tumor development in man and laboratory animals. In the present study, we investigated the effect of a particular type of inescapable footshock stress, known to cause an opioid mediated form of analgesia, on survival time of female Fischer 344 rats injected with a mammary ascites tumor. Rats subjected to inescapable footshock manifested an enhanced tumor growth indicated by a decreased survival time and decreased percent survival. This tumor enhancing effect of stress was prevented by the opiate antagonist, naltrexone, suggesting a role for endogenous opioid peptides in this process. In the absence of stress, naltrexone did not affect tumor growth.
D000230:Adenocarcinoma / Q000150:complications / Q000503:physiopathology*; D000818:Animals; D003692:Delayed-Action Preparations; D004597:Electroshock; D004723:Endorphins / Q000502:physiology*; D005260:Female; D006801:Humans; D008325:Mammary Neoplasms, Experimental / Q000150:complications / Q000503:physiopathology*; D009270:Naloxone / Q000031:analogs & derivatives*; D009271:Naltrexone / Q000627:therapeutic use*; D051381:Rats; D011916:Rats, Inbred F344; D013315:Stress, Psychological / Q000150:complications / Q000503:physiopathology*
D003692:Delayed-Action Preparations; D004723:Endorphins; D009270:Naloxone; D009271:Naltrexone